BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23226455)

  • 1. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
    Hirata H; Ueno K; Shahryari V; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2012; 7(11):e51056. PubMed ID: 23226455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
    World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
    Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling.
    Xie X; Pan J; Han X; Chen W
    Chem Biol Interact; 2019 Feb; 300():73-81. PubMed ID: 30639441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
    Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
    Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
    Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
    Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis.
    Xie F; Li Y; Wang M; Huang C; Tao D; Zheng F; Zhang H; Zeng F; Xiao X; Jiang G
    Mol Cancer; 2018 Oct; 17(1):144. PubMed ID: 30285878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
    Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
    J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells.
    Zhang Z; Liu T; Cheng C; Wang J; Wang C; Huang H; Li Y
    Carcinogenesis; 2022 Dec; 43(12):1176-1189. PubMed ID: 36331809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.
    Li C; Dong J; Han Z; Zhang K
    Oncol Res; 2017 Apr; 25(4):617-627. PubMed ID: 27983934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
    Hirata H; Hinoda Y; Ueno K; Shahryari V; Tabatabai ZL; Dahiya R
    Carcinogenesis; 2012 Jan; 33(1):41-8. PubMed ID: 22049531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos.
    Li S; Xu X; Xu X; Hu Z; Wu J; Zhu Y; Chen H; Mao Y; Lin Y; Luo J; Zheng X; Xie L
    Biochem Biophys Res Commun; 2013 Nov; 441(4):976-81. PubMed ID: 24220339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.